Gene · 9340
GLP2R: glucagon like peptide 2 receptor
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. GLP2R: glucagon like peptide 2 receptor. Genes, record 9340. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9340
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O95838 | Glucagon-like peptide 2 receptor | 553 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents38
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 47607 | O95838 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1739 | O95838 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1739 | O95838 | Espacenet |
| EP 4541896 A1 | 2025-04-23 | 272 | O95838 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 29090 | O95838 | Espacenet |
| JP 2025010185 A | 2025-01-20 | 272 | O95838 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 29090 | O95838 | Espacenet |
| JP 2023184465 A | 2023-12-28 | 272 | O95838 | Espacenet |
| WO 2023243495 A | 2023-12-21 | 272 | O95838 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 29090 | O95838 | Espacenet |
1 to 10 of 38
See all 38 patentsDrugs3
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
Trials30
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT07400783 | TEDUGLUTIDE | ClinicalTrials.gov | ||
| NCT06973304 | TEDUGLUTIDE | PHASE3 | ClinicalTrials.gov | |
| NCT05027308 | TEDUGLUTIDE | PHASE3 | 2024-05-16 | ClinicalTrials.gov |
| NCT05023382 | TEDUGLUTIDE | ClinicalTrials.gov | ||
| NCT05018286 | FE 203799 | PHASE3 | ClinicalTrials.gov | |
| NCT04964986 | FE 203799 | PHASE2 | 2025-06-18 | ClinicalTrials.gov |
| NCT04857801 | TEDUGLUTIDE | ClinicalTrials.gov | ||
| NCT04733066 | TEDUGLUTIDE | ClinicalTrials.gov | ||
| NCT04627025 | FE 203799 | PHASE3 | ClinicalTrials.gov | |
| NCT04290429 | TEDUGLUTIDE | EARLY_PHASE1 | ClinicalTrials.gov |
1 to 10 of 30
See all 30 trialsNIH grants304
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GLP2R papers | Newest fiscal year |
|---|---|---|---|
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 5 | 2025 |
| P30DK056338 | Texas Medical Center Digestive Diseases Center | 4 | 2025 |
| I01BX001245 | Luminal Factors Affecting Duodenal Protection and Chemosensing | 2 | 2025 |
| P20GM103446 | Delaware INBRE | 2 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
| P30DK056341 | Washington University Nutrition Obesity Research Center | 2 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 2 | 2025 |
| T32DK007665 | Metabolism and Nutrition Training Program | 2 | 2025 |
| P20GM109036 | Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases | 1 | 2025 |
1 to 10 of 304Source NIH's project files
See all 304 nih grantsPapers528
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative predictive modelling and multi-omics validation reveals potential indicators of clinical heterogeneity in HCC. | Biochem Biophys Res Commun | 2026 | 42759273 | PubTator, text mining | PubMed |
| EVIDENCE OF THE INFLUENCE OF GLUCAGON-LIKE PEPTIDE ANALOGS IN INFLAMMATORY BOWEL DISEASE: A SCOPING REVIEW. | Arq Gastroenterol | 2026 | 42615757 | PubTator, text mining | PubMed |
| Integrative Analysis of Steroid Metabolism-Based Molecular Subtypes Reveals Prognostic Subtypes and Therapeutic Implications in Gastric Cancer. | Cancer Inform | 2026 | 42571211 | PubTator, text mining | PubMed |
| Genetic architecture and cross-platform validation of apolipoprotein A-IV concentrations. | Genome Biol | 2026 | 42449406 | PubTator, text mining | PubMed |
| Glucagon-Like Peptide-2 Receptor: A Master Integrator of Gut-Brain-Liver Communication in Metabolic and Cognitive Health. | Compr Physiol | 2026 | 41943399 | PubTator, text mining | PubMed |
| Exosome-like nanovesicles from acerola for CRISPR-Cas9 ribonucleoprotein delivery to the central nervous system. | Mol Ther Nucleic Acids | 2026 | 41909467 | PubTator, text mining | PubMed |
| Bispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial. | Nat Commun | 2026 | 41876542 | PubTator, text mining | PubMed |
| Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial. | EClinicalMedicine | 2026 | 41768273 | PubTator, text mining | PubMed |
| Identification and Functional Validation of PTH2R as a Therapeutic Target in Lung Adenocarcinoma. | Biomedicines | 2026 | 41751388 | PubTator, text mining | PubMed |
| DNA methylation-mediated silencing of MEOX1 promotes glycolysis and immune evasion in colorectal cancer cells through inhibition of GLP2R transcription. | Cell Biosci | 2026 | 41612494 | PubTator, text mining | PubMed |
1 to 10 of 528
See all 528 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9340
GET https://conductscience.org/api/genes/v1/9340/patents?page=2